{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-040337","form_type":"8-K","ticker":"SRZN","cik":"0001824893","company_name":"Surrozen, Inc./DE","filed_at":"2024-04-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.427907+00:00","generated_at":"2026-06-04T03:49:19.570354+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Surrozen raises $17.5M in private placement with milestone-triggered warrants","bullets":["Issues 1,089,033 shares at $15.50 and pre-funded warrants for 40,000 shares at $15.4999.","Management purchases 2,948 shares at $16.96; total gross proceeds ~$17.5M.","Series A warrants: 1,129,033 shares at $15.50, exercisable for 5 years.","Series B warrants: 1,228,071 shares at $14.25; exercisable after 15-patient enrollment milestone in SZN-043 trial.","Series C/D warrants: each up to 4,375,000 shares at $16.00, exercisable after Phase 1b data or ≥50 patient enrollment."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-040337","json":"https://secwatch.observer/filing/0000950170-24-040337.json","markdown":"https://secwatch.observer/filing/0000950170-24-040337.md","text":"https://secwatch.observer/filing/0000950170-24-040337.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1824893/000095017024040337/0000950170-24-040337-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1824893/000095017024040337/srzn-20240401.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T03:49:19.570354+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4109e1a3c0ca2fbe28dba6d1dbcabad46c4ebc9e","claim":"Surrozen, Inc./DE entered into Securities Purchase Agreement with certain institutional investors and management valued at aggregate gross proceeds of approximately $17.5 million (effective 2024-04-01).","evidence_excerpt":"On April 1, 2024, Surrozen, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”), with certain institutional investors (the “Investors”) and management (together with the Investors, the “Purchasers”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1824893/000095017024040337/0000950170-24-040337-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain institutional investors and management"},{"label":"Value","value":"aggregate gross proceeds of approximately $17.5 million"},{"label":"Effective","value":"2024-04-01"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}